Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-11,238
Closed -$239K 680
2019
Q4
$239K Sell
11,238
-7,653
-41% -$170K 0.01% 679
2019
Q3
$434K Sell
18,891
-56
-0.3% -$1.28K 0.01% 515
2019
Q2
$460K Sell
18,947
-233
-1% -$4.79K 0.01% 524
2019
Q1
$249K Buy
+19,180
New +$336K 0.01% 551
2018
Q4
Sell
-13,161
Closed -$517K 499
2018
Q3
$517K Buy
13,161
+720
+6% +$32.4K 0.03% 341
2018
Q2
$612K Buy
+12,441
New +$706K 0.03% 308

Other funds holding ADNT

Colony Group's ADNT Position: Q1 2020 in Review

Colony Group sold out of Adient (ADNT) in Q1 2020, closing a stake of 11,238 shares — an estimated $239K sold.

Colony Group first reported a position in ADNT in Q2 2018 and held it in 6 quarters. The position peaked at $612K in Q2 2018. 284 funds tracked by Wall St. Rank hold ADNT as of Q1 2020.

  • Colony Group reported no remaining Adient position as of Q1 2020 after selling out during the quarter.
  • Colony Group sold 11,238 Adient shares in Q1 2020, an estimated $239K.
  • Colony Group first reported a position in Adient in Q2 2018 and held it in 6 quarters.
  • Colony Group's Adient position peaked at $612K in Q2 2018.
  • 284 funds tracked by Wall St. Rank held Adient as of Q1 2020.

Based on Colony Group's 13F filing for Q1 2020, filed 18 May 2020.